9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019
The DOI matches its Crossref record; 77 of the 81 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although SGLT2 inhibitor use was not incorporated into American Diabetes Association guidelines until 2019,48”
From Association of race/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US (2021) · cites this paper as [48]
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“Metformin is effective and safe, is inexpensive, and may reduce risk of cardiovascular events and death (40).”
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Maruthur, N. M., Tseng, E., Hutfless, S., Wilson, L. M., Suarez-Cuervo, C., Berger, Z., Chu, Y., Iyoha, E., Segal, J. B., & Bolen, S. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2650 · Cited by 682
Threshold-based insulin-pump interruption for reduction of hypoglycemia
Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303576 · Cited by 652
Research works printed but not linked: 6
- Peters, 2013, American Diabetes Association/JDRF Type 1 Diabetes Sourcebook
- Chiang, 2014, Type 1 diabetes through the life span: a position statement of the American Diabetes Association
- Lexicon Pharmaceuticals . FDA to review ZynquistaTM (sotagliflozin) as potential treatment for type 1 diabetes [Internet], 2018. Available from http://www.lexpharma.com/media-center/news/673-fda-to-review-zynquista-sotagliflozin-as-potential-treatment-for-type-1-diabetes. Accessed 30 September 2018
- Institute for Clinical and Economic Review . Controversies in the management of patients with type 2 diabetes [Internet], December 2014. Available from https://icer-review.org/wp-content/uploads/2015/03/CEPAC-T2D-Final-Report-December-22.pdf. Accessed 9 November 2018
- Lipska, 2018, Association of initiation of basal insulin analogs vs neutral protamine Hagedorn insulin with hypoglycemia-related emergency department visits or hospital admissions and with glycemic control in patients with type 2 diabetes, 53
- Lipska, 2017, Human insulin for type 2 diabetes: an effective, less-expensive option, 23
Cited by
Items 601–700 of 773
Metformin promotes wound healing in senescent fibroblasts by regulating SIRT1 and FAP-α
Çetinavcı, D., Yaşar, V., Yiğittürk, G., & Elbe, H. (2025) · Histochemistry and Cell Biology · doi:10.1007/s00418-025-02431-z · Cited by 2
Kim, J. Y., Kim, N. H., Kwak, S. H., Jung, C. H., Kang, E. S., Moon, J. S., Moon, S. J., Kwon, S. Y., Yoo, J. H., Kim, Y., et al. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2025.2579 · Cited by 3
Akpan, N., Zhou, B., Rasu, R. S., & Sambamoorthi, U. (2025) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2026.32.1.14 · Cited by 2
Metformin: An emerging therapeutic approach for prevention and treatment of preeclampsia
Afghan, S., Quasimi, H., Alam, S., & Alam, I. (2026) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2026.115048 · Cited by 2
Aronson, R., Mahoney, E., Saliu, D., Sze, D., Morel, D. R., Bergquist, L., & Hirsch, L. J. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0356 · Cited by 2
Evaluation of Vitamin B 12 Monitoring in Veterans With Type 2 Diabetes on Metformin Therapy
Runeberg, H. A., Higbea, A. M., Weideman, R. A., & Álvarez, C. A. (2020) · Journal of Pharmacy Practice · doi:10.1177/0897190019899260 · Cited by 2
Noninsulin Diabetes Therapies in Older Adults
Tekin, Z., & Zimmerman, R. S. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.03.001 · Cited by 3
Hoogwerf, B. J., Mackenzie, M., Sealls, W., Cordova, J. M., & Gandhi, P. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00841-x · Cited by 3
Barengolts, E. I., Akbar, A., Layden, B. T., Eisenberg, Y., Priyadarshini, M., Borgia, J. A., Fhied, C. L., Dugas, L. R., & Salim, M. (2020) · Biomedicines · doi:10.3390/biomedicines8110520 · Cited by 2
Garcia, J. N., & de Oliveira, J. C. (2022) · Revista Brasileira de Medicina de Família e Comunidade · doi:10.5712/rbmfc17(44)2428 · Cited by 2
Antidiabetic agents: Do they hit the right targets?
Zhao, Y., Zhang, X., Liang, H., & Wang, L. (2022) · Frigid Zone Medicine · doi:10.2478/fzm-2022-0030 · Cited by 2
Santana, L. A. S., Aragón, C. V. A., & Tituaña, E. T. R. (2022) · Revista Científica y Tecnológica UPSE · doi:10.26423/rctu.v9i2.663 · Cited by 2
Peasah, S. K., Huang, Y., Palli, S. R., Swart, E. C. S., Donato, B. M. K., Pimple, P. M., Bovier, J., Manolis, C. H., & Good, C. B. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.29.2.152 · Cited by 2
Kim, T., Campbell, D. B., Au, F., Ronksley, P. E., Weaver, R. G., & Campbell, D. J. T. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15419 · Cited by 2
Improving Learning Achievement by Applying the Pakem Learning Model
Putri, T., Tabroni, I., Mark, E., & Margarida, K. (2023) · Journal Emerging Technologies in Education · doi:10.55849/jete.v1i4.470 · Cited by 2
“To overcome the above problems to achieve maximum educational (American Diabetes Association, 2019), the role of the teacher is very important and the teacher is expected to be able to convey all the subjects listed in the learning process appropriately and in accordance with the concepts of the…”
MethodSaverskaya, E., Koksharova, E., Noskov, S., Zaikin, P., Banko, V., & Arefeva, A. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-023 · Cited by 1
Yahyavi, S. K., Kristensen, P. L., Hjorthøj, C. R., Hansen, K. B., & Krogh, J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15907 · Cited by 2
El-Reshaid, K., & Al-Bader, S. (2025) · Open Journal of Nephrology · doi:10.4236/ojneph.2025.152019 · Cited by 2
Coats, A. J. S., & Seferovic, P. M. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1429 · Cited by 2
Early onset gestational diabetes mellitus: A case report and importance of early screening
Najmi, A., Atal, S., Sadasivam, B., Singh, P., & Ray, A. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_290_19 · Cited by 2
Ertugliflozin in type 2 diabetes: a profile of its use
Scott, L. J. (2019) · Drugs & Therapy Perspectives · doi:10.1007/s40267-019-00651-7 · Cited by 2
GLP-101: A Diabetes Educator’s Guide to Glucagon-Like-Peptide-1 Receptor Agonists
Gillenwater, B. A., Wakefield, A. N., Triboletti, J. S., Gonzalvo, J. D., & Meredith, A. H. (2019) · AADE in Practice · doi:10.1177/2325160319861453 · Cited by 2
Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus
Ko, S. (2019) · Journal of Korean Diabetes · doi:10.4093/jkd.2019.20.3.142 · Cited by 2
Injectable Therapy for Diabetes Mellitus: Glucagon-Like Peptide-1 Receptor Agonist
Lee, I., & Kang, E. S. (2019) · Journal of Korean Diabetes · doi:10.4093/jkd.2019.20.3.149 · Cited by 2
Janež, A., Örsy, P., Stachlewska, K., Salvesen‐Sykes, K., Billings, L. K., & Philis‐Tsimikas, A. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13944 · Cited by 7
Cogle, S. V., & Hutchison, A. M. (2020) · Physician Assistant Clinics · doi:10.1016/j.cpha.2019.11.006 · Cited by 2
METFORMIN EXERTS CARDIOPROTECTION IN ISOPROTERENOL-INDUCED CARDIOMYOPATHY IN RATS
Лой, Г. Я., Павлюк, Б. В., Крамар, С., Korda, M. M., & Oleshchuk, O. (2020) · Medical and Clinical Chemistry · doi:10.11603/mcch.2410-681x.2019.v.i4.10855 · Cited by 2
Impact of metformin on malignancy in solid organ transplantation
Bartlett, F., January, S. E., Pottebaum, A. A., Horwedel, T. A., & Malone, A. F. (2020) · Clinical Transplantation · doi:10.1111/ctr.13851 · Cited by 2
Jin, X., Kim, E., Huh, K. Y., Hwang, I., Cho, J., Yu, K., & Lee, S. (2020) · Translational and Clinical Pharmacology · doi:10.12793/tcp.2020.28.e2 · Cited by 2
Marx, N., Rydén, L., Brosius, F. C., Ceriello, A., Cheung, M., Cosentino, F., Green, J., Kellerer, M., Koob, S., Kosiborod, M., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0086 · Cited by 2
“42,43 Another example is the Living Standards of Medical Care in Diabetes published by the ADA.”
Rahmah, A. M., Al-Isawi, J. K. T., & Mahdi, O. A. (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00878-5 · Cited by 3
Effect of sodium-glucose cotransporter-2 inhibitors on renal handling of electrolytes
Meena, P., Bhargava, V., Bhalla, A. K., Rana, D. S., & Mantri, A. K. (2021) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-139348 · Cited by 2
Zeng, T., Yuan, H., Ren, J., Li, Y., Hou, J., Du, L., Zhu, J., Chen, L., & Ji, L. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01007-z · Cited by 2
Olusanya, A. W. (2021) · Clinical Diabetology · doi:10.5603/dk.a2021.0043 · Cited by 2
Kang, D. Y., Kim, H., Ko, S., Kim, H., Shinn, J., Kang, M., Byeon, S., Choi, J., Shin, S.-Y., & Kim, H. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e53 · Cited by 2
SGLT2 inhibitors for treating diabetes in people with chronic kidney disease
Natale, P., Tunnicliffe, D. J., Saglimbene, V. M., Toyama, T., Gargano, L., Stallone, G., Ruospo, M., Gesualdo, L., & Strippoli, G. F. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015588 · Cited by 2
Oshman, L. D., Biszewski, M., Carlock, F., Radz, M., Neu, R., & Billings, L. K. (2022) · Clinical Diabetes · doi:10.2337/cd22-0024 · Cited by 2
Infrasound Exposure: High-Resolution Measurements Near Wind Power Plants
Bakker, H. H. C., Alves‐Pereira, M., Mann, R., Summers, R., & Dickinson, P. (2022) · Environmental sciences · doi:10.5772/intechopen.109047 · Cited by 2
The Role of Guidance and Counseling Teachers in Improving Student Learning Success
Hernawan, R. P., Tabroni, I., Zhang, W., & Xu, S. (2023) · Journal Emerging Technologies in Education · doi:10.55849/jete.v1i3.466 · Cited by 2
“Education is an important asset in the life of the nation and (Heidenreich dkk., 2022), because after all there is no advanced nation without quality (American Diabetes Association, 2019) .”
BackgroundHuman Insulin Versus Insulin Analogues: A True Companion Forgotten
Abdi, H. (2019) · Intern J Endocrinol Metab · doi:10.5812/ijem.97054 · Cited by 2
Yuningtyaswari, Hidayati, T., & Adila, A. (2021) · Advances in health sciences research/Advances in Health Sciences Research · doi:10.2991/ahsr.k.210115.026 · Cited by 1
Diabetes Technology and Therapy in the Pediatric Age Group
Maahs, D. M., Prahalad, P., Schweiger, D. Š., & Shalitin, S. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.2508 · Cited by 1
The Role of Metformin as Chemopreventive Strategies for Hepatocellular Carcinoma
Kholili, U., Kurniawan, A. H., Winda, C., Maimunah, U., & Setiawan, P. B. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00065 · Cited by 1
Logro de control metabólico temprano en adultos con diabetes mellitus tipo 2 en Perú
Rocca, J., Sanchez, C., Bardales, D., Alfaro, J. J., Torres-Samamé, L., Burga, J. L., Olmos, C., Torres-Aparcana, H., Barreda, L. M. A., Delgado, C., et al. (2023) · ACTA MEDICA PERUANA · doi:10.35663/amp.2023.401.2554 · Cited by 5
Achievement of ABC Goals in Type 2 Diabetes in Real-life
Chandalia, H. B., Jain, J. D., & Chandalia, S. H. (2024) · Journal of the Association of Physicians of India · doi:10.59556/japi.72.0730 · Cited by 1
“29,30 Most of them were on oral glucose-lowering regime and insulin.”
Fakhri, M., Jamshidbeigi, T., Dehkordi, A. H., Yadollahifarsani, S., Hematian, S., Nourmohammadi, H., Sarokhani, D., Abdan, Z., & Dehkordi, A. H. (2025) · Epidemiology and Health System Journal · doi:10.34172/ehsj.26338 · Cited by 1
“4,5 The effect of metformin on PCa remains unclear, as studies examining the association between PCa and metformin yielded uncertain and sometimes inconsistent results.”
Preconception and Prenatal Medicaid Coverage for Medicaid-Insured Births
Gregory, E. F., Maddox, A. I., Gibson, L., Passarella, M. A., Roberts, E. T., & Lorch, S. A. (2025) · Journal of Women s Health · doi:10.1177/15409996251362599 · Cited by 1
Al-Mahroos, M. I. A. (2025) · Journal Of Advanced Pharmacy Education And Research · doi:10.51847/bghaoo7cwb · Cited by 1
Murane, N., Sprūdža, K. L., Ivanova, J., & Zaļizko, P. (2025) · Health · doi:10.4236/health.2025.1710083 · Cited by 1
Tharavanij, T., Dejkhamron, P., Rawdaree, P., Likitmaskul, S., Santiprabhob, J., Deerochanawong, C., Reutrakul, S., & Nitiyanant, W. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02123-8 · Cited by 1
Sison, J., Jimeno, C., Matawaran, B. J., Ang, I. C. V., & Gonzales, E. M. (2021) · Philippine Journal of Internal Medicine · doi:10.65564/pjim.ae40192771 · Cited by 1
Exploring Hypovitaminosis B12 in New Onset Type 2 Diabetes Mellitus and Prediabetes
Karanth, J. B., Maribashetti, K., & Karanth, G. J. (2026) · Journal of the Association of Physicians of India · doi:10.59556/japi.74.1359 · Cited by 1
Alfares, K., Alosaimi, R. A., Alqurayqiri, B. O., Malibari, R. W., Babader, R. B., Albluwe, G., Taha, S. H. Z., Alharbi, S. A., & Hamdan, R. M. (2025) · Saudi Journal of Internal Medicine · doi:10.4103/sjim.sjim_34_25 · Cited by 1
Meade, L. T., & Mannka, M. L. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019857557 · Cited by 1
Precision Medicine and the Treatment of Type 2 Diabetes Mellitus
Stunek, E. (2020) · UND Scholarly Commons (University of North Dakota) · Cited by 1
Pavlovskyi, L., Shypulin, V. P., Chernyavskyi, V. V., & Linevska, K. Y. (2020) · Public Communication in Science: Philosophical, Cultural, Political, Economic and IT Context · doi:10.36074/15.05.2020.v3.05 · Cited by 1
Type 2 Diabetes Mellitus Management in Older Adults with Dementia
Sohail, M., James, K., & Munshi, M. N. (2020) · Springer eBooks · doi:10.1007/978-3-030-46398-4_6 · Cited by 2
Müller‐Wieland, D., Schütt, K. S., Brandts, J., & Marx, N. (2020) · Herz · doi:10.1007/s00059-020-04946-8 · Cited by 1
Bertomeu‐González, V., Fácila, L., Palau, P., Miñana, G., Núñez, G., de la Espriella, R., Santas, E., Núñez, E., Bodí, V., Chorro, F. J., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12944 · Cited by 1
Imarhia, F. I., & Malveaux, J. (2020) · Federal Practitioner · doi:10.12788/fp.0057 · Cited by 1
Impact of glucose-lowering medications on bone health in diabetes
Choksi, P. U., & Tan, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820605-8.00004-8 · Cited by 1
An adaptive bolus calculator to minimize the impact of inaccurate insulin to carbohydrate ratio
Miranda, F., Abreu, C., & Felgueiras, P. (2020) · AIP conference proceedings · doi:10.1063/5.0026578 · Cited by 1
Gümüş, A. B., Keser, A., Şıklar, Z., & Berberoğlu, M. (2021) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00836-1 · Cited by 1
Ramos, J. R., Polo, L. L., Juanes-Borrego, A. M., Montava, I. A., Puig, M., & Mangues, M. A. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-020-02655-8 · Cited by 1
Guo, L., Chang, B., Chen, L., Yang, L., Liu, Y., Feng, B., & He, Q. (2021) · Scientific Reports · doi:10.1038/s41598-021-83410-x · Cited by 1
Adverse Effects of Medications on Micronutrient Status: From Evidence to Guidelines
Daniels, M. S., Park, B. I., & McKay, D. L. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120420-023854 · Cited by 2
Shi, F., Li, H., Kong, L.-C., Shen, L., Jiang, Y., Gu, Z., & Ge, H. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.658059 · Cited by 1
Yamashita, Y., Inoue, G., Nozaki, Y., Kitajima, R., Matsubara, K., Horii, T., Mohri, J., Atsuda, K., & Matsubara, H. (2021) · BMC Research Notes · doi:10.1186/s13104-021-05844-w · Cited by 1
A Systematic Review of Oral Semaglutide for Type II Diabetes
kumar, A. S., & Gunasekaran, S. (2021) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2021.v68i01.031 · Cited by 1
Association between Flash Glucose Monitors and A1C: A Retrospective Pre-Post Analysis
Tekarli, M., Turner, K. M., & Witt, D. M. (2021) · INNOVATIONS in pharmacy · doi:10.24926/iip.v12i3.3977 · Cited by 1
Resistant arterial hypertension: the search of new approaches to antihypertensive drug therapy
Ob, K., Landar, L. N., Serdyuk, S. V., Васильевич, Б. В., & Тулина, Л. М. (2021) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2021-27-3-309-317 · Cited by 1
Katz, D. H., & Gavin, M. C. (2022) · Springer eBooks · doi:10.1007/978-3-030-88953-1_13 · Cited by 1
Lane, W. S., Favaro, E., Jódar, E., Kelkar, P., Oviedo, A., Sivarathinasami, R., Senior, P. A., Sesti, G., & Franek, E. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01213-3 · Cited by 1
Management of hypercholesterolemia in individuals living with HIV/AIDS
Ahmed, M., Ahmed, M., Mital, D., & Ahmed, M. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85857-1.00006-7 · Cited by 4
Taybani, Z. J., Bótyik, B., Katkó, M., Gyimesi, A., Kempler, P., & Várkonyi, T. T. (2020) · Diabetologia Hungarica · doi:10.24121/dh.2020.4 · Cited by 3
Freichel, M., & Mengel, K. (2019) · Springer eBooks · doi:10.1007/978-3-662-59046-1_15 · Cited by 1
Probiotics in the Management of Diabetes
Mohi-ud-din, R., Mir, R. H., Farooq, S., Wani, T. U., Pottoo, F. H., Mohi-ud-din, A., & Bhat, Z. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-8444-9_4 · Cited by 1
Altay, F. P., Farzaliyeva, A., İyidir, Ö. T., Bozkuş, Y., Kirnap, N. G., Kut, A., Nar, A., & Tütüncü, N. B. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666221124112413 · Cited by 1
Efficacy and Safety of Empagliflozine and Semaglutide (Once Weekly) in T2DM Patients in Shtip
Nakova, V. V., Nakov, Z., Dokuzova, S., Prosheva, T. B., & Krstevska, B. (2023) · PRILOZI · doi:10.2478/prilozi-2023-0008 · Cited by 1
Yılmaz, D., Şahin, E., Akyol, F., Filiz, B. G., & Ezirmik, E. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01307-z · Cited by 1
“Based on these results, current guidelines recommend administration of SGLT2i in patients with T2DM and certain cardiovascular/renal comorbidities (or high risks for these) [2, 3, 13].”
Zhang, D., Jung, Y., Seol, M., Zhou, S., Chaudhary, D., Jeong, J., & Kim, J. (2024) · Current Analytical Chemistry · doi:10.2174/0115734110288849240116045045 · Cited by 1
Evaluating Gliclazide Safety and Effectiveness in the Management of Type 2 Diabetes Mellitus
Patel's, M. (2024) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt/ijisrt24jun1710 · Cited by 1
Zaghloul, N., Awaisu, A., Mahfouz, A., Ali, Z. O., Alyafei, S., & Elewa, H. F. (2024) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-024-01828-5 · Cited by 1
“This is in spite of the publication of dedicated kidney outcome trials including CREDENCE and DAPA-CKD trials [19, 22], as well as the updated guidelines recommendations promoting the use of this novel class in patients with DM and CKD since 2019 [54, 55].”
Synthesis and hypoglycemic properties of new derivatives of 3,12-dioxo-5β-cholan-24-oic acid
Salomatina, O. V., Борисов, С. А., Khvostov, M. V., Комарова, Н. И., Luzina, O. A., & Salakhutdinov, N. F. (2024) · Russian Chemical Bulletin · doi:10.1007/s11172-024-4479-0 · Cited by 1
Liang, S., Dong, Y., Chang, Z., Guo, P., Jia, J., Yang, G., Chen, Y., Dong, L., Xu, X., Cai, T., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1521111 · Cited by 1
Uhrig, J. L., PAGE, S. O., Mishriky, B. M., Patil, S. P., Powell, J. R., Sewell, K. B., MIAN, M. R., & Cummings, D. M. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1599 · Cited by 1
Gæde, P., Johansen, P., Tikkanen, C. K., Pollock, R. F., Hunt, B., & Malkin, S. J. P. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0638-y · Cited by 1
Is It Time to Leave Behind the Concept of Asthma Control and Severity Steps?
Nannini, L. J. (2019) · Journal of Asthma · doi:10.1080/02770903.2019.1690659 · Cited by 1
Al‐Saleh, Y., Sabico, S., Al-Furqani, A., Jayyousi, A., Alromaihi, D., Ba-Essa, E. M., Alawadi, F., Alkaabi, J., Hassanein, M. M., Alsifri, S. N., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01109-8 · Cited by 1
Patel, K. S., & Carbone, A. M. (2020) · Annals of Pharmacotherapy · doi:10.1177/1060028020910246 · Cited by 1
Diabetes Awareness Among Coronary Artery Disease Patients Is Higher in Women Than in Men
Saely, C. H., MADER, A., Heinzle, C. F., Zanolin-Purin, D., LARCHER, B., Vonbank, A., & Drexel, H. (2019) · Diabetes Care · doi:10.2337/dc19-0241
Writers, A. M. (2019) · Drugs & Therapy Perspectives · doi:10.1007/s40267-019-00639-3
CTIM special issue on type 2 diabetes mellitus
Bradley, R. D. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.07.004
From pump to sink: The hydraulic connection of type 2 diabetes
Giugliano, D., Esposito, K., & Ceriello, A. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.06.013
Hong, J. H. (2019) · Journal of Korean Diabetes · doi:10.4093/jkd.2019.20.2.87
Clark, L., Weeda, E. R., Griffin, M. L., Jones, L. A., & Haney, J. S. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019867850
Simon, M., Baudry, T., Hernu, R., Cour, M., & Argaud, L. (2019) · Médecine Intensive Réanimation · doi:10.3166/rea-2019-0127
Putting Heart (and Kidneys) Into Diabetes Care
Brunton, S. (2019) · Clinical Diabetes · doi:10.2337/cd19-0054
Schipf, S., Markus, M. R. P., & Dörr, M. (2021) · Springer Reference Pflege, Therapie, Gesundheit · doi:10.1007/978-3-662-62426-5_54 · Cited by 1
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-12-07
- Volume
- 42
- Issue
- Supplement_1
- Pages
- S90-S102
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4212810717
- Cited by
- 739
- References
- 81
- Citations by year
- 2026: 12 · 2025: 28 · 2024: 30 · 2023: 47 · 2022: 69 · 2021: 126 · 2020: 246 · 2019: 181
- FWCI
- 21.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- glycemic control, pharmacotherapy, antidiabetic drugs, treatment goals, quality of care, clinical guidelines
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Societies, Medical, United States, Practice Guidelines as Topic, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.